Next Generation Sequencing

Next Generation Sequencing Market by Types of Sequencing (Whole Genome Sequencing, Targeted Resequencing, RNA Resequencing, CHIP Sequencing, Methyl Sequencing, Whole Exome Sequencing, and De novo Sequencing), Product Types (Instruments, Reagent & Consumables, and Services), End Users (Hospital & Healthcare Institutions, Academics, and Pharmaceuticals & Biotechnology Companies), Applications (Drug Discover & Personalized Medicine, Diagnostics, Screening, Agriculture & Animal Research, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-2009
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 185
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global next generation sequencing market size is expected to expand at a significant CAGR during the forecast period, 2021–2028. The growth of the market is attributed to advancement of the NGS platform, reduction in the cost of genome sequencing in addition to the increasing cancer incidence, and increasing use of NGS in cancer research.


Next Generation Sequencing Market key takeaways

Next-generation diagnostic sequencing (NGS) technology has potential advantages in determining viral gene sequences and helping scientists understand viral mutations. During the COVID19 pandemic, governments around the world continued to cooperate with the private sector to implement NGS. Next Generation SARSCoV2 RNA qualitative sequencing is a technology that provides scalability, ultra-high throughput, and high speed for genome-wide nucleotide sequencing. NGS is continuously integrated with clinical laboratory analysis, testing and disease diagnosis in health departments around the world. NGS is widely used in pharmacogenomics to speed up the drug discovery process. With the development of next-generation sequencing technology, the number and types of library preparation solutions are also increasing.

Market Trends, Drivers, Restraints, and Opportunities

  • Increasing incidences of prolonged diseases and rising geriatric population is expected to boost the market during the forecast period.
  • Rapid growth of the healthcare industry owing to covid-19 pandemic and advancements in next generation sequencing platform is major factors fueling the market during the forecast period.
  • Rising demand for personalized medicines and investments in genome mapping project by research institutes is anticipated to drive the market during the forecast period.
  • High installation cost and lack of affordability by small academics & research institutes is projected to hamper the market growth.
  • Lack of skilled labor for handling of NGS technology and lack of reimbursement policy for government research institutes act as major factors that can restrict the market growth during the forecast period.
  • Investment in high scale adoption of NGS equipment by private & government bodies to support large scale genome sequencing project is expected to offer significant opportunities for the market players.

Scope of the Report

The report on the global next generation sequencing market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Next Generation Sequencing Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Types of Sequencing (Whole Genome Sequencing, Targeted Resequencing, RNA Resequencing, CHIP Sequencing, Methyl Sequencing, Whole Exome Sequencing, and De novo Sequencing), Product Types (Instruments, Reagent & Consumables, and Services), End Users (Hospital & Healthcare Institutions, Academics, and Pharmaceuticals & Biotechnology Companies), and Applications (Drug Discovery & Personalized Medicine, Diagnostics, Screening, Agriculture & Animal Research, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Thermo Fisher Scientific Inc.; Illumina Inc.; Agilent Technologies; Perkin Elmer Inc.; and F. Hoffmann-La Roche Ltd.

 

Market Segment Insights

The whole genome sequencing segment is projected to hold a major market share

In terms of types of sequencing, the next generation sequencing market is divided into whole genome sequencing, targeted resequencing, RNA resequencing, CHIP sequencing, methyl sequencing, whole exome sequencing, and de novo sequencing. The whole genome sequencing segment is expected to hold a key share of the market during the forecast period.. Whole genome sequencing (WGS) is widely used to obtain information about COVD19 with the maximum possible resolution and is considered to have the potential to change the way we treat the infectious disease COVID19. In the United States, the national institute of health is one of the leading organizations supporting innovative research by increasing funding for sequencing. In addition, a number of technological advancements in whole-genome sequencing are driving market. For example, Machaon diagnostics launched a 48-hour STAT gene detection panel for hemophagocytic lymphohistiocytosis, which is one of the fastest NGS gene detection panels used for hemophagocytic lymphohistiocytosis. These developments by major players and their collaboration with innovative sequencing and diagnostic companies are driving the growth of the entire genome sequencing market.


Next Generation Sequencing Market by type of sequencing

The services segment is expected to grow at a significant pace

On the basis of product types, the next generation sequencing market is segmented into instruments, reagent & consumables, and services. The services segment is expected to hold a key share of the market in the coming years due to the reduction in NGS sequencing costs, rapid adoption of genetic testing, new policies and the medical reimbursement policy. The main reasons for the growth are affordability, use of consumables and release of new products and emerging demand for a new platform for accurate interpretation of DNA data and advancement of bioinformatics. On the other hand, the instrument segment is anticipated to expand at a rapid pace during the forecast period owing to the introduction of technologically advanced and rapid testing tools for fast aging population. In recent years, healthy life expectancy has soared. This trend is expected to shift the focus of the medical device industry from treatment to prevention. The growing awareness among people led them to prefer prevention rather than cure.

The academics segment is anticipated to expand at a rapid high CAGR

Based on end users, the next generation sequencing market is fragmented into hospital & healthcare institutions, academics, and pharmaceuticals & biotechnology companies. The academics segment is expected to hold a key share of the market during the forecast period. Factors driving the growth of market are steady shift in the focus of traditional teaching, emergence of advanced next generation sequencing based technologies, full use of technologies in identifying medical cases like cancer and corona virus, and increasing focus on minimizing errors and profitability of teaching medical procedures.


Next Generation Sequencing Market by End Users

The diagnostics segment is projected to hold a major market share

In terms of applications, the next generation sequencing market is segmented into drug discovery & personalized medicine, diagnostics, screening, agriculture & animal research, and others. The diagnostics segment is expected to hold a key share of the market during the forecast period. Due to the increasing adoption of genetic testing, the demand for cancer diagnosis, and increasing number of service providers, the diagnostic is regarded as an important part of the next-generation sequencing market. The age recommended by the NGS method is based on its ability to make a clinical diagnosis in a short period of time. It is used to diagnose various diseases, such as infectious diseases, immune disorders, human genetic diseases, and non-invasive prenatal period.

North America is anticipated to dominate the market

On the basis of regions, the next generation sequencing market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to dominate the market during the forecast period. The next-generation sequencing technology is becoming popular as a routine clinical diagnostic test, especially after the COVID19 pandemic has increased in the region. COVID19-NGS test was approved by the FDA, which is an amplicon-based next-generation sequencing test for the detection of upper respiratory tract samples from suspected COVID patients. Major players in the market are increasingly concerned about introducing advanced and effective NGS technology in developing countries to meet the needs of whole-genome sequencing for genomic medicine and personalized medicine. In addition, increasing adoption of NGS technology by government and non-government agencies, as well as increased funding from the federal government and private entities, are expected to drive the market.

Segments

Segments Covered in the Report
The global next generation sequencing market has been segmented on the basis of

Types of Sequencing

  • Whole Genome Sequencing
  • Targeted Resequencing
  • RNA Resequencing
  • CHIP Sequencing
  • Methyl Sequencing
  • Whole Exome Sequencing
  • De novo Sequencing

Product Types

  • Instruments
  • Reagent & Consumables
  • Services

End Users

  • Hospital & Healthcare Institutions
  • Academics
  • Pharmaceuticals & Biotechnology Companies

Applications

  • Drug Discovery & Personalized Medicine
  • Diagnostics
  • Screening
  • Agriculture & Animal Research
  • Others

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Thermo Fisher Scientific Inc.
  • Illumina Inc.
  • Agilent Technologies
  • Perkin Elmer Inc.
  • F. Hoffmann-La Roche Ltd.

Competitive Landscape

Key players competing in the next generation sequencing market include Thermo Fisher Scientific Inc.; Illumina Inc.; Agilent Technologies; Perkin Elmer Inc.; and F. Hoffmann-La Roche Ltd.

Some of these players are using several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares.

Next Generation Sequencing Market by key palyers

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Next Generation Sequencing Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Next Generation Sequencing Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Next Generation Sequencing Market - Supply Chain
  4.5. Global Next Generation Sequencing Market Forecast
     4.5.1. Next Generation Sequencing Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Next Generation Sequencing Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Next Generation Sequencing Market Absolute $ Opportunity
5. Global Next Generation Sequencing Market Analysis and Forecast by Applications
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Applications
     5.2.2. Y-o-Y Growth Projections by Applications
  5.3. Next Generation Sequencing Market Size and Volume Forecast by Applications
     5.3.1. Drug Discovery & Personalized Medicine
     5.3.2. Diagnostics
     5.3.3. Screening
     5.3.4. Agriculture & Animal Research
     5.3.5. Others
  5.4. Absolute $ Opportunity Assessment by Applications
  5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Next Generation Sequencing Market Analysis and Forecast by End Users
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by End Users
     6.2.2. Y-o-Y Growth Projections by End Users
  6.3. Next Generation Sequencing Market Size and Volume Forecast by End Users
     6.3.1. Hospital & Healthcare Institutions
     6.3.2. Academics
     6.3.3. Pharmaceuticals & Biotechnology Companies
  6.4. Absolute $ Opportunity Assessment by End Users
  6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Next Generation Sequencing Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Next Generation Sequencing Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Next Generation Sequencing Demand Share Forecast, 2019-2026
8. North America Next Generation Sequencing Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Next Generation Sequencing Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Next Generation Sequencing Market Size and Volume Forecast by Applications
     8.4.1. Drug Discovery & Personalized Medicine
     8.4.2. Diagnostics
     8.4.3. Screening
     8.4.4. Agriculture & Animal Research
     8.4.5. Others
  8.5. Basis Point Share (BPS) Analysis by Applications
  8.6. Y-o-Y Growth Projections by Applications
  8.7. North America Next Generation Sequencing Market Size and Volume Forecast by End Users
     8.7.1. Hospital & Healthcare Institutions
     8.7.2. Academics
     8.7.3. Pharmaceuticals & Biotechnology Companies
  8.8. Basis Point Share (BPS) Analysis by End Users
  8.9. Y-o-Y Growth Projections by End Users
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Next Generation Sequencing Demand Share Forecast, 2019-2026
9. Latin America Next Generation Sequencing Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Next Generation Sequencing Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Next Generation Sequencing Market Size and Volume Forecast by Applications
     9.4.1. Drug Discovery & Personalized Medicine
     9.4.2. Diagnostics
     9.4.3. Screening
     9.4.4. Agriculture & Animal Research
     9.4.5. Others
  9.5. Basis Point Share (BPS) Analysis by Applications
  9.6. Y-o-Y Growth Projections by Applications
  9.7. Latin America Next Generation Sequencing Market Size and Volume Forecast by End Users
     9.7.1. Hospital & Healthcare Institutions
     9.7.2. Academics
     9.7.3. Pharmaceuticals & Biotechnology Companies
  9.8. Basis Point Share (BPS) Analysis by End Users
  9.9. Y-o-Y Growth Projections by End Users
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Next Generation Sequencing Demand Share Forecast, 2019-2026
10. Europe Next Generation Sequencing Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Next Generation Sequencing Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Next Generation Sequencing Market Size and Volume Forecast by Applications
     10.4.1. Drug Discovery & Personalized Medicine
     10.4.2. Diagnostics
     10.4.3. Screening
     10.4.4. Agriculture & Animal Research
     10.4.5. Others
  10.5. Basis Point Share (BPS) Analysis by Applications
  10.6. Y-o-Y Growth Projections by Applications
  10.7. Europe Next Generation Sequencing Market Size and Volume Forecast by End Users
     10.7.1. Hospital & Healthcare Institutions
     10.7.2. Academics
     10.7.3. Pharmaceuticals & Biotechnology Companies
  10.8. Basis Point Share (BPS) Analysis by End Users
  10.9. Y-o-Y Growth Projections by End Users
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Next Generation Sequencing Demand Share Forecast, 2019-2026
11. Asia Pacific Next Generation Sequencing Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Next Generation Sequencing Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Next Generation Sequencing Market Size and Volume Forecast by Applications
     11.4.1. Drug Discovery & Personalized Medicine
     11.4.2. Diagnostics
     11.4.3. Screening
     11.4.4. Agriculture & Animal Research
     11.4.5. Others
  11.5. Basis Point Share (BPS) Analysis by Applications
  11.6. Y-o-Y Growth Projections by Applications
  11.7. Asia Pacific Next Generation Sequencing Market Size and Volume Forecast by End Users
     11.7.1. Hospital & Healthcare Institutions
     11.7.2. Academics
     11.7.3. Pharmaceuticals & Biotechnology Companies
  11.8. Basis Point Share (BPS) Analysis by End Users
  11.9. Y-o-Y Growth Projections by End Users
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Next Generation Sequencing Demand Share Forecast, 2019-2026
12. Middle East & Africa Next Generation Sequencing Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Next Generation Sequencing Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Next Generation Sequencing Market Size and Volume Forecast by Applications
     12.4.1. Drug Discovery & Personalized Medicine
     12.4.2. Diagnostics
     12.4.3. Screening
     12.4.4. Agriculture & Animal Research
     12.4.5. Others
  12.5. Basis Point Share (BPS) Analysis by Applications
  12.6. Y-o-Y Growth Projections by Applications
  12.7. Middle East & Africa Next Generation Sequencing Market Size and Volume Forecast by End Users
     12.7.1. Hospital & Healthcare Institutions
     12.7.2. Academics
     12.7.3. Pharmaceuticals & Biotechnology Companies
  12.8. Basis Point Share (BPS) Analysis by End Users
  12.9. Y-o-Y Growth Projections by End Users
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Next Generation Sequencing Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Next Generation Sequencing Market: Market Share Analysis
  13.2. Next Generation Sequencing Distributors and Customers
  13.3. Next Generation Sequencing Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. Thermo Fisher Scientific Inc.
     13.4.2. Illumina Inc.
     13.4.3. Agilent Technologies
     13.4.4. Perkin Elmer Inc.
     13.4.5. F. Hoffmann-La Roche Ltd.

Segments Covered in the Report
The global next generation sequencing market has been segmented on the basis of

Types of Sequencing

  • Whole Genome Sequencing
  • Targeted Resequencing
  • RNA Resequencing
  • CHIP Sequencing
  • Methyl Sequencing
  • Whole Exome Sequencing
  • De novo Sequencing

Product Types

  • Instruments
  • Reagent & Consumables
  • Services

End Users

  • Hospital & Healthcare Institutions
  • Academics
  • Pharmaceuticals & Biotechnology Companies

Applications

  • Drug Discovery & Personalized Medicine
  • Diagnostics
  • Screening
  • Agriculture & Animal Research
  • Others

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Thermo Fisher Scientific Inc.
  • Illumina Inc.
  • Agilent Technologies
  • Perkin Elmer Inc.
  • F. Hoffmann-La Roche Ltd.

Key players competing in the next generation sequencing market include Thermo Fisher Scientific Inc.; Illumina Inc.; Agilent Technologies; Perkin Elmer Inc.; and F. Hoffmann-La Roche Ltd.

Some of these players are using several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares.

Next Generation Sequencing Market by key palyers

Buy Report